When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine-Reference-Cited by-同舟云学术

When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine

Published:2017-07 Issue:1 Volume:57 Page:18-27
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Beers Michael F.¹,Moodley Yuben²

Affiliation:

1. Lung Epithelial Biology Laboratories, Penn Center for Pulmonary Biology, Pulmonary and Critical Care Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and

2. University of Western Australia, Harry Perkins Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

http://www.atsjournals.org/doi/pdf/10.1165/rcmb.2016-0426PS

Reference122 articles.

1. The three R’s of lung health and disease: repair, remodeling, and regeneration

2. Cellular Mechanisms of Tissue Fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosis

3. Telomere dysfunction causes alveolar stem cell failure

4. The Acute Respiratory Distress Syndrome

5. The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building a human lung from pluripotent stem cells to model respiratory viral infections;Respiratory Research;2024-07-15

2. Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis;Science Advances;2024-07-12

3. Cell–cell interactions and communication dynamics in lung fibrosis;Chinese Medical Journal Pulmonary and Critical Care Medicine;2024-06

4. SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failure;Trials;2024-05-18

5. Qingkailing granule alleviates pulmonary fibrosis by inhibiting PI3K/AKT and SRC/STAT3 signaling pathways;Bioorganic Chemistry;2024-05